SLAMF9: A Potential Drug Target and Biomarker (G89886)
SLAMF9: A Potential Drug Target and Biomarker
SLAMF9, or Signaling lymphocytic activation molecule family member 9, is a protein that is expressed in a variety of tissues, including the brain, spinal cord, and peripheral tissues. It is a member of the SLAM family, which includes several other proteins that are involved in the regulation of T cell development and function.
SLAMF9 has been identified as a potential drug target due to its involvement in the regulation of T cell proliferation and differentiation. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. They are produced in the bone marrow and are responsible for responding to antigens in the body.
SLAMF9 has been shown to regulate the development and function of T cells in several ways. For example, studies have shown that SLAMF9 can inhibit the activity of the DNA-binding protein p53, which is responsible for regulating T cell growth and differentiation. This suggests that SLAMF9 may be a useful target for drugs that are designed to promote T cell growth and proliferation.
Another way that SLAMF9 may be a drug target is its role in the regulation of the immune response. T cells are a key part of the immune system, and they play a critical role in detecting and responding to foreign substances in the body. SLAMF9 has been shown to regulate the activity of T cells, which suggests that it may be a useful target for drugs that are designed to enhance the immune response.
In addition to its potential as a drug target, SLAMF9 may also be a useful biomarker for the diagnosis and monitoring of certain diseases. For example, studies have shown that changes in the level of SLAMF9 have been associated with the development of several diseases, including cancer and autoimmune disorders. This suggests that SLAMF9 may be a useful biomarker for the diagnosis and monitoring of these diseases.
Overall, SLAMF9 is a protein that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in the regulation of T cell development and function, as well as its potential as a drug and biomarker.
Protein Name: SLAM Family Member 9
Functions: May play a role in the immune response
More Common Targets
SLBP | SLC corepressor complex | SLC10A1 | SLC10A2 | SLC10A3 | SLC10A4 | SLC10A5 | SLC10A6 | SLC10A7 | SLC11A1 | SLC11A2 | SLC12A1 | SLC12A2 | SLC12A2-DT | SLC12A3 | SLC12A4 | SLC12A5 | SLC12A5-AS1 | SLC12A6 | SLC12A7 | SLC12A8 | SLC12A9 | SLC13A1 | SLC13A2 | SLC13A3 | SLC13A4 | SLC13A5 | SLC14A1 | SLC14A2 | SLC15A1 | SLC15A2 | SLC15A3 | SLC15A4 | SLC15A5 | SLC16A1 | SLC16A10 | SLC16A11 | SLC16A12 | SLC16A13 | SLC16A14 | SLC16A2 | SLC16A3 | SLC16A4 | SLC16A5 | SLC16A6 | SLC16A6P1 | SLC16A7 | SLC16A8 | SLC16A9 | SLC17A1 | SLC17A2 | SLC17A3 | SLC17A4 | SLC17A5 | SLC17A6 | SLC17A7 | SLC17A8 | SLC17A9 | SLC18A1 | SLC18A2 | SLC18A3 | SLC18B1 | SLC19A1 | SLC19A2 | SLC19A3 | SLC1A1 | SLC1A2 | SLC1A3 | SLC1A4 | SLC1A5 | SLC1A6 | SLC1A7 | SLC20A1 | SLC20A1-DT | SLC20A2 | SLC22A1 | SLC22A10 | SLC22A11 | SLC22A12 | SLC22A13 | SLC22A14 | SLC22A15 | SLC22A16 | SLC22A17 | SLC22A18 | SLC22A18AS | SLC22A2 | SLC22A20P | SLC22A23 | SLC22A24 | SLC22A25 | SLC22A3 | SLC22A31 | SLC22A4 | SLC22A5 | SLC22A6 | SLC22A7 | SLC22A8 | SLC22A9 | SLC23A1